NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Vagustim

Vagustim

Private
United StatesHealthcare & Life Scienceshttps://vagustim.io/

Last Round

Crowdfunding

Nov 6, 2025

Total Funding Raised

$454,796

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Vagustim is a therapeutic devices company that develops a wearable neuromodulation device designed to electrically stimulate the vagus nerve in both ears.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Mental Health, D2C Brands, Health IoT

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

vagus nerve stimulationVNSauricular vagus nerve stimulationvagus nerve stimulatorneuromodulationwearable wellness devicenon-invasive stimulationstress relief deviceneurotechd2c medical devicenervous system regulationsleep improvementbiohackingautonomic nervous systemhealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vagustim Comparables

Compare Vagustim with similar companies based on industry and business-model similarity.

Vagustim comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Parasym
91%
ZenoWell
90%
Neuvana
86%

Vagustim Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingNov 6, 2025
GrantJun 7, 2022
AcceleratorJan 25, 2022

Key People

Founding team and executive leadership

Ali Can Erk

Co-Founder & CEO

Founding Team

ONUR YUSUF ÇINAR

Chief Technology Officer

Executive Team

Vagustim Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased to 14, 2.8x the trailing average.

  • May 2, 2025

    Monthly visitors increased 79% MoM to 20.4K.

Vagustim Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vagustim Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vagustim's valuation, stock price, and market status.

Firmographic Details

HeadquartersUnited States
Employee Range12
Year Founded2019
Last FundingNov 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.